07:18 AM EST, 11/03/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) reported Q3 non-GAAP earnings Monday of $0.16 per diluted share, up from $0.02 a year earlier.

Analysts polled by FactSet expected $0.07.

Revenue for the quarter ended Sept. 30 was $159.4 million, up from $117.1 million a year earlier.

Analysts polled by FactSet expected $$163 million.

The company said it remains on track to post a net income and positive cash flows for 2025.

Shares of BioCryst were down more than 4% in recent premarket activity Monday.

Price: 7.01, Change: -0.31, Percent Change: -4.23